Table 3.
Summary of squamous EC patients with synchronous SPC
Case no. | Age (yr)/Sex | EC |
SPC |
Survival, mon | ||||
---|---|---|---|---|---|---|---|---|
Clinical stagea | Treatment | Location | Detection | Clinical stagea | Treatment | |||
1 | 74/M | cT1N0M0, I | Esophagectomy | Hypopharynx | CT | cT1N0M0, I | BSC | 54.3 |
2 | 55/M | cT3N1M0, III | Palliative CTX | Hypopharynx | CT | cT2N0M0, II | Laryngopharyngectomy, CRT | 24.5 |
3 | 82/M | cT2N1M0, IIB | Definitive CRT | Hypopharynx | CT | cT3N2M0, IVA | Palliative RTX | 4.9 |
4 | 49/M | cT1N0M0, I | Esophagectomy | Oropharynx | PET-CT | cT1N0M0, I | Definitive RTX | 43.0 |
5 | 61/M | cT1N0M0, I | Esophagectomy | Lung | CT | cT1aN0M0, IA | Lobectomy | 65.3 |
6 | 76/M | cT2N1M0, IIB | Definitive CRT | Lung | CT | cT1bN0M0, IA | Radiosurgery | 19.3 |
7 | 70/M | cT1N0M0, I | BSC | Lung | CT | cT1aN0M0, IA | BSC | 71.9 |
8 | 67/M | cT2N1M0, IIB | Esophagectomy, CRT | Lung | CT | cT1aN0M0, IA | Wedge resection | 36.9 |
9 | 70/M | cT3N1M0, III | Palliative CRT | Stomach | Endoscopy | cT4N1M0, IV | Palliative CRT | 3.9 |
10 | 68/M | cT3N1M0, III | Esophagectomy, CRT | Stomach | Endoscopy | cT3N2M0, IIIB | Gastrectomy, CRT | 25.8 |
11 | 52/M | cT1N1M0, IIB | BSC | Stomach | Endoscopy | cT3N3M1, IV | BSC | 0.4 |
12 | 83/M | cT3N1M1b, IVb | Palliative CTX | Stomach/lung | Endoscopy/CT | cT3N3M1, IV/cT2aN3M1,IV | Palliative CTX | 1.6 |
13 | 68/M | cT1N0M0, I | Definitive CRT | Colon | PET-CT | cT3N0M0, IIA | Colectomy | 11.8 |
14 | 76/M | cT4N1M0, III | Definitive CRT | Colon | PET-CT | cT1N0M0, I | Mucosectomy | 72.5 |
15 | 59/M | cT1N0M0, I | Palliative CTX | Pancreas | CT | cT3N1M0, IIB | Pancreatectomy, CTX | 26.5 |
16 | 74/M | cT2N1M0, IIB | BSC | Pancreas | CT | cT2N1M0, IIB | BSC | 8.1 |
17 | 77/M | cT1N0M0, I | BSC | Pancreas | CT | cT2N0M0, IB | BSC | 4.4 |
18 | 76/M | cT4N1M0, III | Palliative CRT | Bile duct | CT | cT2N0M0, II | BSC | 6.8 |
19 | 78/M | cT2N1M0, IIB | Esophagectomy | Gallbladder | PET-CT | cT1N0M0, IA | Cholecystectomy | 20.2 |
20 | 39/F | cT3N1M1b, IVb | Palliative CRT | Thyroid | CT | cT2N1aM0, III | BSC | 4.0 |
21 | 77/M | cT2N1M0, IIB | Definitive CRT | Liver | CT | cT3N0M0, IIIA | BSC | 4.8 |
EC, esophageal cancer; SPC, second primary cancers; CT, computed tomography; BSC, best supportive care; CTX, chemotherapy; RTX, radiotherapy; CRT, chemoradiotherapy; PET, 18F-fluorodeoxyglucose positron emission tomography.
Clinical stage determined according to the American Joint Committee on Cancer, 6th edition.